EMBRACing Change: The 1st International Study of Liquid Biopsy for Brain Tumors | Prof. Paul Brennan

What does the future of brain tumor diagnosis, treatment, and patient outcomes look like ? In this session, Dr. Paul Brennan, Professor of clinical and experimental neurosurgery and honorary consultant neurosurgeon at the University of Edinburgh and NHS Lothian, UK takes us on a journey through the importance of early brain tumor detection, innovative liquid biopsy approaches using spectroscopy. With his expertise and extensive work spanning laboratory, epidemiological and clinical investigation he also shares valuable message for future clinicians and researchers. Watch the full session and join the conversation! About the Neurological Liquid Biopsy The Neurological Liquid Biopsy Symposium Co-founded and moderated by Leonora Balaj, PhD, and Anudeep Yekula, MD, is a monthly virtual forum fostering scientific exchange and interdisciplinary discussion at the intersection of neuroscience, neurosurgery, biomarker discovery, and translational research. Subscribe for future sessions and scientific discussions. #LiquidBiopsy #Neurosurgery #BrainTumors #NeuroOncology #Biomarkers Timestamps- 00:00 – Welcome and Introductions | Dr. Leonora Balaj and Dr. Anudeep Yekula 04:00 – The Rationale Behind the EMBRACE Trial 11:50 – Why Early Diagnosis Matters in Brain Tumors 12:42 – The effect of tumour size on Diagnostic Delay in Brain Tumors 14:41 – Neoadjuvant therapies: Emerging Treatment Strategies 15:31 – ADePT: AAV-1– Mediated Dual-Payload Gene Therapy for High-Grade Glioma 17:20 – Verbal Fluency a Cognitive Test as Screening Tool for Suspected Brain Tumors 19:34 – Emerging Liquid Biopsy Strategies for Brain Tumor Detection 20:01 – Spectroscopic Liquid Biopsy for Early Detection Brain Cancer 29:56 – The EMBRACE Trial: Study Design and Clinical Research 50:46 – Overcoming Challenges in Clinical Brain Tumor Research 52:56 – Advice for the Next Generation of Clinicians and Researchers